Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Comment by CleverInvestor2on Jan 31, 2020 10:52pm
196 Views
Post# 30628325

RE:RE:The Rockerfeller Family Added More TRIL

RE:RE:The Rockerfeller Family Added More TRIL
birch1 wrote: anyone think this is $15 to $20 in the next 2 months?


That's why I haven't sold my shares yet. The long term gain is worth the short term pain.... and by long term, I mean 1-2 years at most.

Our next big NR and Run up should happen in June when they release further updates on their clinical trails of the CD47 and TTI 621.

As of right now, our medicines looks better than current market leaders, we just have to prove it.
If our medicine is a successful as expected, we can be trading at $20-40USD in no time. We just need to wait for the next update which is due in June
<< Previous
Bullboard Posts
Next >>